Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ESAB CorpESAB · Entity 3958 | SVP, EBX & Supply Chain | April 05, 2022 | April 08, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ESAB Corp
Report date April 05, 2022 · Filed April 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 4,438 |
Reported balance
After 2022-04-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-04-05 · Grant · Acquired 4,438 · Balance 4,438 F1: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2022-08-07 | Direct | 245 |
Reported balance
After 2022-04-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-04-05 · Grant · Acquired 245 · Balance 245 F2: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4: These restricted stock units vest and become exercisable in a single installment on August 7, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2023-02-24 | Direct | 670 |
Reported balance
After 2022-04-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-04-05 · Grant · Acquired 670 · Balance 670 F2: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2023-07-25 | Direct | 911 |
Reported balance
After 2022-04-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-04-05 · Grant · Acquired 911 · Balance 911 F2: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2024-02-22 | Direct | 2,007 |
Reported balance
After 2022-04-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-04-05 · Grant · Acquired 2,007 · Balance 2,007 F2: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2025-02-17 | Direct | 5,210 |
Reported balance
After 2022-04-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-04-05 · Grant · Acquired 5,210 · Balance 5,210 F2: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F8: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.49 · Expires 2026-02-24 | Direct | 11,424 |
Reported balance
After 2022-04-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-04-05 · Grant · Acquired 11,424 · Balance 11,424 F9: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.94 · Expires 2027-02-23 | Direct | 6,138 |
Reported balance
After 2022-04-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-04-05 · Grant · Acquired 6,138 · Balance 6,138 F9: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10: 5,101 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.96 · Expires 2028-02-21 | Direct | 7,415 |
Reported balance
After 2022-04-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-04-05 · Grant · Acquired 7,415 · Balance 7,415 F9: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F11: 3,081 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.04 · Expires 2024-11-06 | Direct | 22,370 |
Reported balance
After 2022-04-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-04-05 · Grant · Acquired 22,370 · Balance 22,370 F9: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.63 · Expires 2025-03-07 | Direct | 6,402 |
Reported balance
After 2022-04-05 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-04-05 · Grant · Acquired 6,402 · Balance 6,402 F9: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB").
F2: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock.
F3: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award.
F4: These restricted stock units vest and become exercisable in a single installment on August 7, 2022.
F5: These restricted stock units vest and become exercisable in a single installment on February 24, 2023.
F6: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023.
F7: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024.
F8: These restricted stock units vest in three equal annual installments beginning on February 17, 2023.
F9: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option.
F10: 5,101 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023.
F11: 3,081 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 6,402 | $0.00 Strike: $41.63 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 11 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,402 Underlying: Common stock, par value $0.001 · 6,402 shares Expires 2025-03-07 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 22,370 | $0.00 Strike: $46.04 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 10 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,370 Underlying: Common stock, par value $0.001 · 22,370 shares Expires 2024-11-06 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 7,415 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 9 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,415 Underlying: Common stock, par value $0.001 · 7,415 shares Expires 2028-02-21 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F11 · derivative.exercise_date: 3,081 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 6,138 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 8 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138 Underlying: Common stock, par value $0.001 · 6,138 shares Expires 2027-02-23 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10 · derivative.exercise_date: 5,101 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantEmployee Stock Option (right to buy) · Derivative | 11,424 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 7 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,424 Underlying: Common stock, par value $0.001 · 11,424 shares Expires 2026-02-24 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 5,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 6 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,210 Underlying: Common stock, par value $0.001 · 5,210 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F8 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 2,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 5 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,007 Underlying: Common stock, par value $0.001 · 2,007 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 911 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 4 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911 Underlying: Common stock, par value $0.001 · 911 shares Expires 2023-07-25 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 670 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 3 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670 Underlying: Common stock, par value $0.001 · 670 shares Expires 2023-02-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · derivative · entry 2 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 Underlying: Common stock, par value $0.001 · 245 shares Expires 2022-08-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on August 7, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:44 UTC | ESAB Corp ESAB · Entity 3958 | GrantCommon stock, par value $0.001 | 4,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023780 · doc4.xml · nonDerivative · entry 1 Coble Larry · CIK 0001912591 · SVP, EBX & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,438 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.